Latest News

The real story ahead of the PPI and Retail Sales reports is Treasury rates, which continue to rise despite yesterday’s soft CPI report.

We’re in the early stages of a “Great Rotation” out of overvalued U.S. equities and into hard assets like gold, silver, and commodities.

The Mexican Peso strengthens as US-China tariff pause boosts risk appetite; USD retreats after a rally on policy shift rumors.

A criminal probe of Medicare fraud follows the second warning on costs in a month.

The company pays a $0.785 per share quarterly dividend, which comes out to a 3.2% yield.

Since February, the log EPU has moved about two standard deviations.

The Tariff discount is over - maybe it will reappear - but markets appear to think a return to punitive tariffs is over.

The disruption brought by the new Trump administration -- especially around global trade -- has brought recession concerns back to the forefront.

The AUD/USD pair remains near the bottom of its daily range, reflecting cautious sentiment amid mixed technical signals.

With PPI on deck Thursday, traders are bracing for signs of tariff pass-through creeping into producer costs. That keeps the Fed sidelined and rate cut hopes on ice.

Temporary turbulence has resulted in opportunity for patient, bargain-hunting investors.

This quantum computing play is still a volatile investment.

The US market regular session of Wednesday is over, let's have a look at the top gainers and losers in the after hours session today.

Medical technology company Teleflex (NYSE:TFX) met Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 5% year on year to $700.7 million. Its non-GAAP profit of $2.91 per share was 0.9% above analysts’ consensus estimates.

Beauty products company Estée Lauder (NYSE:EL) reported Q1 CY2025 results topping the market’s revenue expectations, but sales fell by 9.9% year on year to $3.55 billion. Its non-GAAP profit of $0.65 per share was significantly above analysts’ consensus estimates.

Electrical supply company WESCO (NYSE:WCC) announced better-than-expected revenue in Q1 CY2025, but sales were flat year on year at $5.34 billion. Its non-GAAP profit of $2.21 per share was 4.7% below analysts’ consensus estimates.

BofA Securities analyst Kevin Fischbeck downgrades UnitedHealth Group from Buy to Neutral.

American firearm manufacturing company Ruger (NYSE:RGR) fell short of the market’s revenue expectations in Q1 CY2025, with sales flat year on year at $135.7 million. Its non-GAAP profit of $0.46 per share was 29.2% below analysts’ consensus estimates.

Machine vision technology company Cognex (NASDAQ:CGNX) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 2.5% year on year to $216 million. On the other hand, next quarter’s revenue guidance of $245 million was less impressive, coming in 0.6% below analysts’ estimates. Its non-GAAP profit of $0.16 per share was 19.4% above analysts’ consensus estimates.